|
|
Volumn 71, Issue 4, 2014, Pages 263-
|
|
Dapagliflozin approved for type 2 diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DAPAGLIFLOZIN;
GLIMEPIRIDE;
INSULIN;
METFORMIN PLUS PIOGLITAZONE;
SITAGLIPTIN;
2 (3 (4 ETHOXYBENZYL) 4 CHLOROPHENYL) 6 HYDROXYMETHYLTETRAHYDRO 2H PYRAN 3,4,5 TRIOL;
2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL;
ANTIDIABETIC AGENT;
GLUCOSIDE;
DIABETIC KETOACIDOSIS;
DIET THERAPY;
EXERCISE;
GLYCEMIC CONTROL;
HUMAN;
HYPOVOLEMIA;
MYCOSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
RECOMMENDED DRUG DOSE;
URINARY TRACT INFECTION;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
UNITED STATES;
DIABETES MELLITUS, TYPE 2;
DRUG APPROVAL;
GLUCOSIDES;
HUMANS;
HYPOGLYCEMIC AGENTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84906655523
PISSN: 10792082
EISSN: 15352900
Source Type: Journal
DOI: 10.2146/news140013 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
